RESPONSE ONCOLOGY INC
10-Q, EX-27, 2000-11-14
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: RESPONSE ONCOLOGY INC, 10-Q, EX-10.V, 2000-11-14
Next: MANUFACTURERS LIFE INSURANCE CO OF NORTH AMERICA, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000763098
<NAME> RESPONSE ONCOLOGY
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           7,857
<SECURITIES>                                         0
<RECEIVABLES>                                   13,894
<ALLOWANCES>                                     2,602
<INVENTORY>                                      2,960
<CURRENT-ASSETS>                                42,510
<PP&E>                                          17,071
<DEPRECIATION>                                  13,470
<TOTAL-ASSETS>                                 109,967
<CURRENT-LIABILITIES>                           51,851
<BONDS>                                              0
                                0
                                         17
<COMMON>                                           123
<OTHER-SE>                                      46,306
<TOTAL-LIABILITY-AND-EQUITY>                   109,967
<SALES>                                         99,952
<TOTAL-REVENUES>                                99,952
<CGS>                                           68,450
<TOTAL-COSTS>                                  101,700
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   405
<INTEREST-EXPENSE>                               2,548
<INCOME-PRETAX>                                (2,193)
<INCOME-TAX>                                     (830)
<INCOME-CONTINUING>                            (1,363)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,363)
<EPS-BASIC>                                      (.11)
<EPS-DILUTED>                                    (.11)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission